Wu Shu, Ge Yuanlong, Huang Laiqiang, Liu Haiying, Xue Yong, Zhao Yong
a The School of Life Sciences ; Tsinghua University ; Beijing , PR China.
Cell Cycle. 2014;13(18):2869-78. doi: 10.4161/15384101.2014.946834.
Telomerase is often upregulated during initiation and/or progression of human tumors, suggesting that repression of telomerase might inhibit cancer growth or progression. Here, we report that BRG1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is a general suppressor of hTERT transcription in human cancer cells. While overexpression of BRG1 inhibits hTERT transcription, depletion of BRG1 stimulates transcription of hTERT, leading to higher telomerase activity and longer telomeres. Chromatin-immunoprecipitation assays revealed that BRG1 binds to the transcription start site (TSS) of the hTERT promoter and forms a ternary complex with histone deacetylase 2 (HDAC2). BRG1 remodels chromatin structure to facilitate the action of HDAC2, leading to deacetylation of H3K9ac and H4ac at the TSS and suppression of hTERT transcription. On the other hand, β-catenin binds to the TSS and stimulates hTERT transcription. Thus, BRG1/HDAC2 and β-catenin constitute a manipulative apparatus at the TSS to play opposite but complementary roles in regulating hTERT expression. These results uncover a yin-yang mechanism in modulating hTERT transcription and provide explanation for limited transcription of hTERT in human cancer cells. BRG1/HDAC2 may have a potential as an anti-cancer therapeutic and/or for reactivating cellular proliferative capacity in the context of in vitro tissue engineering.
端粒酶在人类肿瘤的起始和/或进展过程中常常上调,这表明抑制端粒酶可能会抑制癌症生长或进展。在此,我们报告称,SWI/SNF染色质重塑复合物的ATP酶亚基BRG1是人类癌细胞中hTERT转录的一般抑制因子。BRG1的过表达会抑制hTERT转录,而BRG1的缺失则会刺激hTERT转录,导致更高的端粒酶活性和更长的端粒。染色质免疫沉淀分析显示,BRG1与hTERT启动子的转录起始位点(TSS)结合,并与组蛋白去乙酰化酶2(HDAC2)形成三元复合物。BRG1重塑染色质结构以促进HDAC2的作用,导致TSS处的H3K9ac和H4ac去乙酰化,并抑制hTERT转录。另一方面,β-连环蛋白与TSS结合并刺激hTERT转录。因此,BRG1/HDAC2和β-连环蛋白在TSS处构成一个调控装置,在调节hTERT表达中发挥相反但互补的作用。这些结果揭示了一种调节hTERT转录的阴阳机制,并解释了人类癌细胞中hTERT转录受限的原因。BRG1/HDAC2可能具有作为抗癌治疗和/或在体外组织工程背景下重新激活细胞增殖能力的潜力。